Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Dirk Rades und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de. Hauptthemen laut MEDLINE: Breast Neoplasms, Peripheral Nervous System Diseases, Taxoids, Bridged-Ring Compounds.
Abstract (Originalsprache)
BACKGROUND/AIM: Many patients with non-metastatic breast cancer assigned to radiotherapy already received taxane-based chemotherapy, often associated with peripheral neuropathy (PNP). Since treatment options are limited, identification of high-risk patients is important. Therefore, we developed two risk scores. PATIENTS AND METHODS: Previously, we identified risk factors for moderate to severe PNP. Now, risk scores were developed including four (Score A=performance score, cardiovascular disease, smoking history, beta blocker medication) or five (Score B=plus autoimmune disease) factors, respectively. For each existing factor, patients received 1 point; three risk groups were formed. RESULTS: PNP rates using Score A were 11.1% (0 points), 37.5% (1-2 points), and 100% (3 points). Positive (PPV) and negative (NPV) predictive values were 100% and 88.9%. PNP rates using Score B were 7.4% (0 points), 33.8% (1-2 points), and 90.9% (3-4 points). PPV and NPV were 90.9% and 92.6%, respectively. CONCLUSION: Both risk scores provided high accuracy with respect to identification of patients with low or high risk of moderate to severe PNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
- Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
- Department for Human Medicine, MSH Medical School Hamburg, Hamburg, Germany.
- Department of Hematology, Oncology and Stem Cell Transplantation, Helios Hospital Schwerin, Schwerin, Germany.
- Department of Obstetrics and Gynecology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
- Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
Zitieren
APA
Rades, D., Bartscht, T., Rody, A., & Ballegaard, M. (2025). Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17586
Vancouver
Rades D, Bartscht T, Rody A, Ballegaard M. Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17586
BibTeX
@article{Rades2025,
author = {Rades, Dirk and Bartscht, Tobias and Rody, Achim and Ballegaard, Martin},
title = {Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17586}
}
EUVIMED